Merit Medical Systems Inc (MMSI)
99.07
+0.27
(+0.27%)
USD |
NASDAQ |
Nov 04, 16:00
100.79
+1.72
(+1.74%)
After-Hours: 07:46
Merit Medical Systems Max Drawdown (5Y): 60.66% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 60.66% |
September 30, 2024 | 60.66% |
August 31, 2024 | 61.42% |
July 31, 2024 | 68.68% |
June 30, 2024 | 68.68% |
May 31, 2024 | 68.68% |
April 30, 2024 | 68.68% |
March 31, 2024 | 68.68% |
February 29, 2024 | 68.68% |
January 31, 2024 | 68.68% |
December 31, 2023 | 68.68% |
November 30, 2023 | 68.68% |
October 31, 2023 | 68.68% |
September 30, 2023 | 68.68% |
August 31, 2023 | 68.68% |
July 31, 2023 | 68.68% |
June 30, 2023 | 68.68% |
May 31, 2023 | 68.68% |
April 30, 2023 | 68.68% |
March 31, 2023 | 68.68% |
February 28, 2023 | 68.68% |
January 31, 2023 | 68.68% |
December 31, 2022 | 68.68% |
November 30, 2022 | 68.68% |
October 31, 2022 | 68.68% |
Date | Value |
---|---|
September 30, 2022 | 68.68% |
August 31, 2022 | 68.68% |
July 31, 2022 | 68.68% |
June 30, 2022 | 68.68% |
May 31, 2022 | 68.68% |
April 30, 2022 | 68.68% |
March 31, 2022 | 68.68% |
February 28, 2022 | 68.68% |
January 31, 2022 | 68.68% |
December 31, 2021 | 68.68% |
November 30, 2021 | 68.68% |
October 31, 2021 | 68.68% |
September 30, 2021 | 68.68% |
August 31, 2021 | 68.68% |
July 31, 2021 | 68.68% |
June 30, 2021 | 68.68% |
May 31, 2021 | 68.68% |
April 30, 2021 | 68.68% |
March 31, 2021 | 68.68% |
February 28, 2021 | 68.68% |
January 31, 2021 | 68.68% |
December 31, 2020 | 68.68% |
November 30, 2020 | 68.68% |
October 31, 2020 | 68.68% |
September 30, 2020 | 68.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
60.66%
Minimum
Sep 2024
68.68%
Maximum
Nov 2019
68.29%
Average
68.68%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Boston Scientific Corp | 43.49% |
Abbott Laboratories | 33.88% |
Baxter International Inc | 64.18% |
Becton Dickinson & Co | 29.62% |
Perspective Therapeutics Inc | 91.70% |